Stock Update (NYSE:CVS): CVS Health Corporation Announces Final Results of Tender Offers

[PR Newswire] – WOONSOCKET, R.I., June 14, 2016 /PRNewswire/ — CVS Health Corporation (“CVS Health” or the “Company”, NYSE: CVS) announced today the final results of its previously announced cash … Read more on this. CVS Health Corporation (CVS) , currently valued at $103.52B, opened this morning at $95.71. Looking at today’s trading action, the company’s one day range from $95.43 to $96.71 with its 52-week range being $81.37 to $113.65. Priced at 16.43x this year’s forecasted earnings, CVS shares are relatively expensive compared to the industry’s 10.44x forward p/e ratio. And for dividend hunters, the company pays shareholders $1.70 per share annually in dividends, yielding 1.76%. In a review of the consensus earnings estimate this quarter, 24 sell-side analysts are looking at $1.30 per share, which would be $0.08 better than the year-ago quarter and a $0.05 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $5.83 is a $0.67 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $44.30 Billion. If reported, that would be a 19.18% increase over the year-ago quarter. Recently, Atlantic Equities Initiated CVS at Overweight (Feb 3, 2016). Previously, Robert W. Baird Initiated CVS at to Outperform. Given all the information above, we should disclose to readers that the average price target is $114.24, which is 19.36% above than it opened this morning. See more in (NYSE:CVS) Similar Articles: Company Update (NYSE:CVS): CVS Health Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount Market Update (NYSE:CVS): CVS Health Corporation Announces Cash Tender Offers for Certain Outstanding Notes Stock Update (NYSE:CVS): CVS Health Corporation Announces Quarterly Dividend